Birth Defects and Developmental Disabilities - Prevention and Surveillance

 

To work with State health agencies, universities, and public and private nonprofit organizations in planning, implementing coordinating or evaluating programs, research or surveillance activities related to improved birth outcomes, prevention of birth defects, and the improvement of infant and child health and developmental outcomes. To provide a national, State or local focus for the prevention of conditions of persons with birth defects; to employ epidemiological methods to set priorities, build capacity and direct health promotion interventions for persons with birth defects; to expand public health training opportunities through fellowships to introduce geneticists, epidemiologists, and clinicians to public health practice through education, training and career-enhancing experiences. To enhance surveillance and research for birth defects; to prevent congenital heart defects and other major birth defects associated with medication use during pregnancy; to advance neural tube defect prevention; and enhance the quality and usefulness of newborn screening data and programs.

Active 93.073 Centers For Disease Control and Prevention, Department of Health and Human Services B - Project Grants Not applicable.
Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Part 75 Section 301(a) of the Public Health Service, 42 U.S.C. 241(a), 317(k)(2) of the Public Health Service Act, 42 U.S.C. 247b(k)(2). Not applicable. State; Consumer; Local; Public nonprofit institution/organization; Federally Recognized Indian Tribal Governments; Individual/Family; Private nonprofit institution/organizations and others. Costs under CDC financial assistance mechanisms are in accordance with 2 CFR ?200, as codified in 45 CFR ?75. Any required credentials and/or documentation will be identified in the NOFO to which applications are submitted. Preapplication coordination is not applicable. This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial awards provide funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, award requirements, and special conditions, if any. Contact the headquarters or regional location, as appropriate for application deadlines From 90 to 120 days. Not applicable. Cooperative agreement period of performance is 1 to 5 years. After initial awards, and subject to availability of funds, projects may be continued non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government. If additional support is desired to continue a project beyond the approved project period, an application for competing continuation must be submitted for review in the same manner as a new application. Projects are renewable for periods of 1 to 4 years. In general, applications are reviewed on the basis of scientific/technical merit, with attention given to such matters as: (1) The degree to which the applicant satisfies the essential requirements and possesses other desired characteristics, such as depth, breadth, and merit of the overall application relative to the types of projects proposed; (2) clarity of purpose and overall qualifications, adequacy and appropriateness of personnel to accomplish proposed prevention research projects and demonstration projects, and the nation's health priorities and needs; (3) ability to generalize, translate and disseminate to State or local health departments, and other appropriate national regional, and local public health agencies and organizations; (4) reasonableness of the proposed budget in relation to the work proposed. Funds may be used to strengthen, to expand, to build upon or to enhance research, surveillance, health promotion, education, prevention/intervention activities that contribute to the mission and activities of the Division of Birth Defects and Infant Disorders. Funds may be used to improve and strengthen State and local public health infrastructure by providing technical assistance to other appropriate health agencies, organizations, special groups or coalitions. Funds may be used to support capacity building, program planning, development, implementation, evaluation, and surveillance for birth defects, infant and child health and developmental outcomes, including related health promotion, education and training, prevention/intervention. Funds may also be used to coordinate the dissemination of prevention information to the general public, target populations and among state and local agencies and public and private sector organizations in the United States. Funds may not be used for direct curative or rehabilitative services. Performance Reports: Annual Federal Financial Reports (FFR) and performance/progress reports are required. Final FFRs and performance reports are required. Other reporting may be required and will be outlined in the NOFO or the Notice of Award. Not applicable. In accordance with 2 CFR ?200, as codified in 45 CFR ?75, there is a 3-year record retention requirement; records shall be retained beyond the 3-year period if final audit has not been done or findings resolved. Property records must be retained in accordance with HHS Grants Policy Statement requirements. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient. Notice of Award None/Not specified. Shelia Jones
1600 Clifton Rd
Atlanta, GA 30043 US
sjones3@cdc.gov
Phone: 3 http://www.cdc.gov/ncbddd 75-0958-1-1-550 (Cooperative Agreements) FY 22$22,258,136.00; FY 23 est $23,059,867.00; FY 24 est $23,059,867.00; FY 21$26,630,227.00; FY 20$32,505,000.00; - Range is dependent upon funding availability and specific grant activities. Award amounts range from $20,000 to $2,000,000. Regulations governing this program are published under 45 CFR Part 75. Additional requirements are indicated in the HHS Grants Policy Statement. Not applicable.